156 results match your criteria Temporal Bone Acquired Cholesteatoma


Evidence for Oncolytic Viral Eradication of Cholesteatoma In Vitro.

Otolaryngol Head Neck Surg 2019 Jan 1:194599818821863. Epub 2019 Jan 1.

5 Division of Hematology, Oncology, Blood and Marrow Transplant, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA.

Cholesteatomas (CHSTs) are congenital or acquired lesions of the temporal bone that are associated with significant morbidity. We hypothesized that an oncolytic herpes simplex virus (oHSV) could preferentially eradicate primary human CHST cells in vitro and that this virus will replicate selectively and efficiently in CHST cells when compared with control cells. In this work, primary human CHST cells were cultured from surgically collected tissue. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599818821863DOI Listing
January 2019

Cholesteatoma Pearls: Practical Points and Update.

Authors:
James T Castle

Head Neck Pathol 2018 Sep 1;12(3):419-429. Epub 2018 Aug 1.

Department of Oral & Maxillofacial Pathology, Naval Postgraduate Dental School, Naval Medical Professional Development Center, 8955 Wood Road, Bethesda, MD, 20889-5638, USA.

The European Academy of Otology and Neurotology in collaboration with the Japanese Otological Society (EAONO/JOS) recently produced a joint consensus document outlining the definitions, classification and staging of middle ear cholesteatoma. The goals were to provide terminologies in the description of cholesteatoma, classify cholesteatoma into distinct categories to facilitate the comparison of surgical outcomes and to provide a staging system that reflects the severity, difficulty of complete removal and restoration of normal function. Cholesteatoma is considered a benign, expanding and destructive epithelial lesion of the temporal bone that is the result of a multifactorial process. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-018-0915-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081285PMC
September 2018
2 Reads

Lateral semicircular canal osteoma presenting as chronic postaural fistula.

BMJ Case Rep 2018 May 12;2018. Epub 2018 May 12.

Skull Base Unit, Queen Elizabeth Hospital, Birmingham, UK.

Temporal bone osteoma is an unusual pathology which can occur by birth or can be acquired and mostly involves the tympanomastoid segment of the temporal bone. Osteomas arising from the otic capsule are extremely rare, and there has been only one other report of a lateral semicircular canal osteoma in the literature. We report a similar case of an acquired lateral canal osteoma which presented as a chronic postaural fistula in an ear previously operated for paediatric cholesteatoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2017-223794DOI Listing
May 2018
2 Reads

Challenges and outcomes of cholesteatoma management in children with Down syndrome.

Int J Pediatr Otorhinolaryngol 2018 Mar 2;106:80-84. Epub 2018 Feb 2.

Ann & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Otolaryngology-Head and Neck Surgery, Chicago, IL, United States; Northwestern University Feinberg School of Medicine, Department of Otolaryngology-Head and Neck Surgery, Chicago, IL, United States. Electronic address:

Introduction: The high incidence of chronic otitis media with effusion and Eustachian tube dysfunction in children with Down syndrome (DS) may predispose them to cholesteatoma formation. Establishing the diagnosis, choosing the appropriate operative intervention, and post-operative care can be challenging.

Objective: To describe management strategies for cholesteatoma diagnosis, surgical treatment, and post-operative management in children with Down syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijporl.2018.01.016DOI Listing
March 2018
5 Reads

Five-year postoperative outcomes of modified staged canal wall up tympanoplasty for primary acquired cholesteatoma.

Eur Arch Otorhinolaryngol 2018 Mar 11;275(3):691-698. Epub 2018 Jan 11.

Department of Otolaryngology, Kamio Memorial Hospital, Tokyo, Japan.

Objective: For successful canal wall up tympanoplasty (CWUT) for the treatment of cholesteatoma, the restoration of stable middle ear aeration is also important; however, little is known about the dynamics of such aeration or the optimal surgical procedure. In this study, alternative additional surgical procedure was selected based on the grade of middle ear aeration during the second-stage operation.

Subjects And Methods: Patients included in this study underwent staged CWUT surgeries with mastoid cortex plasty (MCP) for well-aerated ears (grade 3) and bony mastoid obliteration (BMO) for poorly aerated ears (grade 2-0). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-018-4863-1DOI Listing
March 2018
4 Reads

Superior semicircular canal dehiscence: A new perspective.

Eur J Radiol Open 2017 14;4:144-146. Epub 2017 Nov 14.

Department of Radiodiagnosis DRPGMC, Tanda, Kangra, H.P., India.

Objective: To determine the use of multi-detector computed tomography (MDCT) in the diagnostic interpretation of superior semicircular canal dehiscence (SSCD) or thinning and its association with ear pathologies and to find whether it is an acquired condition and its association with increase in age.

Materials And Methods: study was performed in a tertiary care institute present in a village, following approval of the institutional ethical committee. Retrospective review of temporal bone CT examinations performed between September 2016 and March 2017 was done. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23520477173003
Publisher Site
http://dx.doi.org/10.1016/j.ejro.2017.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717502PMC
November 2017
10 Reads

MDCT of the temporal bone and audiological findings of pediatric acquired cholesteatoma.

Eur Arch Otorhinolaryngol 2017 Nov 21;274(11):3959-3964. Epub 2017 Aug 21.

Department of Radiology, Ondokuz Mayis University Faculty of Medicine, 55139, Atakum, Samsun, Turkey.

Cholesteatoma is a benign epithelial lesion affecting the middle ear and/or mastoid process, causing otorrhea and hearing loss. Here, we retrospectively evaluated the temporal multidetector computed tomography and audiological findings of acquired cholesteatoma in children. Forty-three patients younger than 18 years old with middle ear acquired cholesteatoma were evaluated with regard to their clinical symptoms, temporal multidetector computed tomography findings, and audiometry results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-017-4721-6DOI Listing
November 2017
14 Reads

Why does the acquired cholesteatoma trigger resorption of the temporal bone?

Eur Arch Otorhinolaryngol 2017 12 14;274(12):4251-4252. Epub 2017 Jun 14.

Department of Oral Surgery, Medical University of Gdansk, Smoluchowskiego 17, 80-214, Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-017-4633-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663803PMC
December 2017
3 Reads

A Case Report of a Giant Cholesteatoma.

J Clin Diagn Res 2017 Mar 1;11(3):ED08-ED10. Epub 2017 Mar 1.

Specialist, Department of ENT, Deen Dayal Upadhyay Hospital, Delhi, India.

Cholesteatoma is a well demarcated, non-neoplastic, temporal bone cystic lesion with extensive keratinisation. Keratoma and epidermoid cyst are other possibly more accurate names suggested to describe the same. It can be classified as congenital or acquired. Read More

View Article

Download full-text PDF

Source
http://jcdr.net/article_fulltext.asp?issn=0973-709x&year
Publisher Site
http://dx.doi.org/10.7860/JCDR/2017/17688.9574DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427326PMC
March 2017
35 Reads

Practicality analysis of the staging system proposed by the Japan Otological Society for acquired middle ear cholesteatoma: A multicenter study of 446 surgical cases in Japan.

Auris Nasus Larynx 2018 Feb 6;45(1):45-50. Epub 2017 Mar 6.

Department of Otorhinolaryngology, Mitsui Memorial Hospital, Japan. Electronic address:

Objective: The Objective of this study was to assess the practicality of the cholesteatoma staging system proposed by the Japan Otological Society (JOS) for acquired middle ear cholesteatoma (the 2010 JOS staging system).

Methods: Between 2009 and 2010, 446 ears with retraction pocket cholesteatoma underwent primary surgery at 6 institutions in Japan. The extent of cholesteatoma was surgically confirmed, and classified into three stages. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anl.2017.02.005DOI Listing
February 2018

Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.

Clin Exp Otorhinolaryngol 2017 Sep 12;10(3):213-220. Epub 2017 Jan 12.

Department of Pathology, Fujita Health University School of Medicine, Toyoake, Japan.

Objectives: Cholesteatoma is a nonneoplastic destructive lesion of the temporal bone with debated pathogenesis and bone resorptive mechanism. Both molecular and cellular events chiefly master its activity. Continued research is necessary to clarify factors related to its aggressiveness. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21053/ceo.2016.01263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545701PMC
September 2017
11 Reads

Attic cholesteatoma with closure of the entrance to pars flaccida retraction pocket.

Auris Nasus Larynx 2017 Dec 29;44(6):766-770. Epub 2016 Dec 29.

Department of Otolaryngology, Jichi Medical University, Saitama Medical Center, Saitama-shi, Omiya-ku, Amanuma-cho 1-847, Saitama, Japan.

We report three patients with pars flaccida-type cholesteatoma (attic cholesteatoma) with closure of the entrance to the cholesteatoma at the time of surgery. These patients were diagnosed with attic cholesteatoma requiring surgery on the basis of abnormal findings of the pars flaccida, audiometry, and temporal bone computed tomography during the clinical course. Intraoperatively, cholesteatoma matrix and granulation tissue were observed behind the intact pars flaccida epithelium, which suggested that the entrance had apparently closed and the continuity with the cholesteatoma matrix disappeared after resolution of inflammation at the pars flaccida. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03858146163028
Publisher Site
http://dx.doi.org/10.1016/j.anl.2016.11.014DOI Listing
December 2017
5 Reads

The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.

Eur Arch Otorhinolaryngol 2017 May 16;274(5):2071-2078. Epub 2016 Dec 16.

Department of Otolaryngology-Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.

Cholesteatoma is a destructive squamous epithelial lesion of the temporal bone which gradually expands and leads to serious complications by destruction of nearby bony structures. Erosion caused by bone resorption of the ossicular chain and bony labyrinth may result in hearing loss, vestibular dysfunction, facial paralysis, labyrinthine fistulae and intracranial complications. The exact underlying cellular and molecular mechanism of bone resorption in acquired cholesteatoma still remains unexplained. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-016-4422-6DOI Listing
May 2017
10 Reads

Presence of osteoclasts in middle ear cholesteatoma: a study of undecalcified bone sections.

Acta Otolaryngol 2017 Feb 30;137(2):127-130. Epub 2016 Aug 30.

a Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine , University of Occupational and Environmental Health , Kitakyushu , Japan.

Conclusions: Osteoclasts are unlikely to be involved in bone resorption in middle ear cholesteatoma.

Objective: The authors searched for osteoclasts in undecalcified bone sections in patients with middle ear cholesteatoma to determine whether and to what extent these cells are involved in this disease.

Methods: Twelve patients, eight men and four women, aged 30-87 years, who underwent tympanomastoidectomy were enrolled. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00016489.2016.1222549DOI Listing
February 2017
2 Reads

Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Clin Exp Otorhinolaryngol 2016 Dec 21;9(4):298-308. Epub 2016 Jul 21.

Department of Otolaryngology, Second Hospital, Fujita Health University School of Medicine, Nagoya, Japan.

Cholesteatoma is a cystic non tumorous lesion of the temporal bone that has the ability to destroy nearby structures by its power to cause bone resorption and as a result, fatal complications prevail. We aimed to conduct a comprehensive review for pathogenesis of acquired cholesteatoma, bone resorption mechanisms, and offer a future vision of this serious disease. We have reviewed different theories for pathogenesis of acquired cholesteatoma including the most relevant and updated ones with special emphasis on the mechanisms of bone resorption through Medline/PubMed research using the keywords 'aetiopathogenesis, bone resorption, acquired cholesteatoma, temporal bone, and cytokines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21053/ceo.2015.01662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115149PMC
December 2016
13 Reads

[Advance research on the pathogenesis of middle ear cholesteatoma].

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016 Feb;30(4):338-41

Cholesteatoma is a non-neoplastic, keratinizing lesion, characterized by the proliferation of epithelium with aberrant micro-architecture into the middle ear or mastoid cavity. The exact pathogenic molecular mechanisms behind the formation and propagation of cholesteatoma remain unclear. Without timely detection and intervention, cholesteatomas can become dangerous and result in numerous intracranial and extracranial complications. Read More

View Article

Download full-text PDF

Source
February 2016
3 Reads

Iatrogenic cholesteatoma arising from the vascular strip.

Laryngoscope 2017 03 16;127(3):698-701. Epub 2016 Jun 16.

Department of Otorhinolaryngology, Mayo Clinic School of Medicine, Rochester, Minnesota, U.S.A.

Objectives/hypothesis: To highlight the phenomenon of cholesteatoma arising from the vascular strip following tympanoplasty and tympanomastoidectomy.

Study Design: Multi-institutional retrospective chart review.

Methods: Consecutive adult and pediatric patients evaluated between 2000 and 2015 with acquired cholesteatoma arising from the skin of a prior vascular strip were identified. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.26093DOI Listing
March 2017
12 Reads

[Analyses of the operative efficacy of 102 cases of acquired middle ear cholesteatoma].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016 May;51(5):338-42

Department of Otorhinolaryngology, the First Hospital of China Medical University, Shenyang 110001, China.

Objective: To investigate the efficacy of operations of acquired middle ear cholesteatoma.

Methods: Retrospectively analyzed clinical data of 102 patients whom received tympanoplasty with CWU or CWD with mastoid obliteration in our hospital between January 2014 and December 2014. Patients were divided into different groups according to types of the cholesteatoma as well as the different surgical procedures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1673-0860.2016.05.005DOI Listing
May 2016
6 Reads

Giant Petrous Bone Cholesteatoma: Combined Microscopic Surgery and an Adjuvant Endoscopic Approach.

J Neurol Surg Rep 2016 Mar;77(1):e46-9

Organi di Senso Department, Sapienza University of Rome, Rome, Italy.

Petrous bone cholesteatomas (PBCs) are epidermoid cysts, which have developed in the petrous portion of the temporal bone and may be congenital or acquired. Cholesteatomas arising in this region have a tendency to invade bone and functional structures and the middle and posterior fossae reaching an extensive size. Traditionally, surgery of a giant PBC contemplates lateral transtemporal or middle fossa microscopic surgery; however, in recent years, endoscopic surgical techniques (primary or complementary endoscopic approach) are starting to receive a greater consensus for middle ear and mastoid surgeries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0035-1571205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773824PMC
March 2016
3 Reads

Is endoscopic ear surgery an alternative to the modified Bondy technique for limited epitympanic cholesteatoma?

Eur Arch Otorhinolaryngol 2016 Sep 7;273(9):2533-40. Epub 2016 Jan 7.

Department of Otology and Skull Base Surgery, Gruppo Otologico, C/o Casa di Cura Piacenza Privata spa, Via Emmanueli, 42, Piacenza, Rome, 29121, Italy.

The objective of this study is to evaluate the outcomes of the modified Bondy's technique performed at our center and for limited epitympanic cholesteatomas and to debate the purported benefits of endoscopic surgery for the same indication. This is a retrospective study. 269 ears of 258 patients with a minimum of 5-year follow-up that were operated for limited epitympanic cholesteatoma using the modified Bondy's technique were included in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-015-3883-3DOI Listing
September 2016
33 Reads
1 Citation
1.610 Impact Factor

Multidimensional staging system for pediatric acquired cholesteatoma: A 30-year verification data.

Auris Nasus Larynx 2016 Aug 9;43(4):387-94. Epub 2015 Oct 9.

Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; Department of Otolaryngology, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC. Electronic address:

Objective: This article presents a points-based prognostic prediction model for pediatric acquired cholesteatoma, incorporating the multidimensional factors that contribute to surgical failure.

Methods: This study included 132 ears with acquired cholesteatoma from 128 children (≤18 years) identified between 1982 and 2012. Each case was scored for the extent of the cholesteatoma, history of grommet insertion, age of the patient, ossicular destruction, and otorrhea. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anl.2015.09.007DOI Listing
August 2016
4 Reads
1.004 Impact Factor

Endoscopic versus transcranial procurement of allograft tympano-ossicular systems: a prospective double-blind randomized controlled audit.

Cell Tissue Bank 2016 Jun 5;17(2):199-204. Epub 2015 Sep 5.

Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium.

Allograft tympano-ossicular systems (ATOS) have proven their use over many decades in tympanoplasty and reconstruction after resection of cholesteatoma. The transcranial bone plug technique has been used in the past 50 years to procure en bloc ATOS (tympanic membrane with malleus, incus and stapes attached). Recently, our group reported the feasibility of the endoscopic procurement technique. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10561-015-9531-8DOI Listing
June 2016
5 Reads

Pediatric middle ear cholesteatoma: the comparative study of congenital cholesteatoma and acquired cholesteatoma.

Eur Arch Otorhinolaryngol 2016 May 5;273(5):1155-60. Epub 2015 Jun 5.

Department of Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine, Asahimachi-dori 1, Chuo-ku, Niigata, 951-8510, Japan.

This study examined the differences between congenital cholesteatoma (CC) and acquired cholesteatomas (AC) in children by comparing clinical features and treatment courses. This was a retrospective study which retrospectively evaluated 127 children with middle ear cholesteatomas using medical records from January 1999 to December 2012 in the Department of Otolaryngology, Niigata University Hospital. The study comprised 69 and 58 cases of CC and AC, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-015-3679-5DOI Listing
May 2016
3 Reads

Osseous eustachian tube and peritubal cells in patients with unilateral cholesteatoma comparison between healthy and diseased sides using high-resolution cone-beam computed tomography.

Otol Neurotol 2015 Jun;36(5):776-81

*Department of Otolaryngology, Takanoko Hospital, Matsuyama, Ehime; and †Department of Otolaryngology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Objectives: We investigated the factors that may possibly cause primary acquired cholesteatoma.

Setting: University-affiliated hospital.

Subjects And Methods: In 20 adult patients with unilateral cholesteatoma, the sizes of the osseous eustachian tubes (ETs) and the extent of peritubal and mastoid cell development in healthy and diseased ears were examined using high-resolution cone-beam computed tomography. Read More

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/otology-neurotology/2015/06000/
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MAO.0000000000000711DOI Listing
June 2015
7 Reads

Endoscopic exclusive transcanal approach to the tympanic cavity cholesteatoma in pediatric patients: our experience.

Int J Pediatr Otorhinolaryngol 2015 Mar 7;79(3):316-22. Epub 2015 Jan 7.

Otolaryngology Department, University Hospital of Modena, Via del Pozzo 71, 41100 Modena, Italy.

Objectives: The aim of the present study is to describe our experience in the management of tympanic cavity cholesteatoma in pediatric patients, treated with endoscopic exclusive transcanal approach.

Methods: A chart review of clinical data and videos from the operations of 54 pediatric patients, undergoing surgery between January 2007 and December 2013, was made. Patients presenting with cholesteatoma involving the tympanic cavity (mesotympanum, epitympanum, protympanum and/or hypotympanum), with no mastoid involvement, were included in the first group and underwent an exclusive transcanalar endoscopic approach (TEA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijporl.2014.12.008DOI Listing
March 2015
21 Reads

A review of current progress in acquired cholesteatoma management.

Eur Arch Otorhinolaryngol 2015 Dec 17;272(12):3601-9. Epub 2014 Sep 17.

Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei, 112, Taiwan, ROC.

The aim of this study was to review recent advances in the management of acquired cholesteatoma. All papers referring to acquired cholesteatoma management were identified in Medline via OVID (1948 to December 2013), PubMed (to December 2013), and Cochrane Library (to December 2013). A total of 86 papers were included in the review. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-014-3291-0DOI Listing
December 2015
1 Read
4 Citations
1.610 Impact Factor

Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research.

Authors:
Chin-Lung Kuo

Laryngoscope 2015 Jan 14;125(1):234-40. Epub 2014 Aug 14.

Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital; Department of Otolaryngology, National Yang-Ming University School of Medicine; Institute of Brain Science, National Yang-Ming University; Department of Otolaryngology, National Defense Medical Center, Taipei, Taiwan, R.O.C.; Department of Otolaryngology, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan, R.O.C.

Objective: To review recent biomolecular advances in etiopathogenesis of acquired cholesteatoma.

Data Sources: MEDLINE via OVID (to March 2014) and PubMed (to March 2014).

Review Methods: All articles referring to etiopathogenesis of acquired cholesteatoma were identified in the above databases, from which 89 articles were included in this review. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.24890DOI Listing
January 2015
4 Reads
15 Citations
2.032 Impact Factor

Clinical analysis of secondary acquired cholesteatoma.

Am J Otolaryngol 2014 Sep-Oct;35(5):589-93. Epub 2014 Jun 5.

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Objective: This study aimed to analyze the clinical features of patients who underwent surgery for secondary acquired cholesteatoma (SAC).

Materials And Methods: The subjects were 30 patients who underwent surgery for SAC in 30 ears. We investigated the age distribution, sex, tympanic membrane (TM) findings, temporal bone pneumatization, morphology of TM epidermis invasion, extent of cholesteatoma invasion, ossicular erosion, surgical methods and surgical results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjoto.2014.05.009DOI Listing
May 2015
5 Reads

Middle ear cholesteatoma: Compared diagnostic performances of two incremental MRI protocols including non-echo planar diffusion-weighted imaging acquired on 3T and 1.5T scanners.

J Neuroradiol 2015 Jul 9;42(4):193-201. Epub 2014 Jul 9.

Faculty of Medicine, Louis-Pasteur University, 67000 Strasbourg, France; Laboratory of Biostatistics and Medical Informatics, Louis-Pasteur University, 67000 Strasbourg, France.

Background And Purpose: To compare diagnostic performances for cholesteatoma diagnosis of incremental MRI protocols including non-echo planar diffusion-weighted imaging (DWI) performed on 3T and 1.5T scanners.

Materials And Methods: Thirty-nine patients with suspected cholesteatoma underwent 3T and 1. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01509861140017
Publisher Site
http://dx.doi.org/10.1016/j.neurad.2014.02.003DOI Listing
July 2015
22 Reads

Acquired cholesteatoma in children: clinical features and surgical outcome.

Auris Nasus Larynx 2014 Oct 2;41(5):417-21. Epub 2014 Jun 2.

Department of Otolaryngology-Head and Neck surgery, Faculty of Medicine, Niigata University, Japan.

Objective: In general, cholesteatoma tends to recur more frequently in children than in adults. This has been suggested to be due to immature Eustachian tube function, underdeveloped mastoid air cells, and subsequent repetitive otitis media in children. This study was undertaken to determine the characteristics of acquired cholesteatoma in children by comparison with that in adults. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anl.2014.05.002DOI Listing
October 2014
6 Reads

Long-term follow-up results of canal wall down tympanoplasty with mastoid obliteration using the bone pate plate for canal wall reconstruction in cholesteatoma surgery.

Otol Neurotol 2014 Jul;35(6):961-5

Department of Otolaryngology Head and Neck Surgery, Niigata University Faculty of Medicine, Niigata, Japan.

Background: The pathogenesis of recurrent cholesteatoma can be roughly divided into residual lesions and re-retraction of the epithelium. To prevent both residual and re-retraction cholesteatoma, we performed canal wall down tympanoplasty with mastoid obliteration using the bone pate plate for canal wall reconstruction as a fundamental surgical treatment for patients with acquired cholesteatoma. We attempted to achieve the complete extirpation of cholesteatoma in the wide surgical field made by the canal wall down procedure and simultaneously prevent recurrent retraction cholesteatoma and regain the physiologic canal wall, in which patients can have a "maintenance-free ear. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0000000000000414DOI Listing
July 2014
8 Reads

Acquired middle ear cholesteatoma in children with cleft palate: experience from 18 surgical cases.

Int J Pediatr Otorhinolaryngol 2014 Jun 15;78(6):918-22. Epub 2014 Mar 15.

Department of Clinical and Experimental Medicine, Unit of Audiology and Pediatric Otorhinolaryngology, University of Parma, Italy.

Objectives: To review an institutional experience with the surgical management of middle ear cholesteatoma in children with cleft palate.

Materials And Methods: We analyzed retrospectively 18 children diagnosed with cleft palate who underwent surgery for acquired middle ear cholesteatoma between 2000 and 2007. The following data were recorded: age, sex, history of ventilation tube insertion, status of the contralateral ear, cholesteatoma location and extension, and surgical technique involved. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijporl.2014.03.007DOI Listing
June 2014
5 Reads

[Acquired pediatric cholesteatoma: predictive factors of recurrence. A retrospective study of 11 years].

J Med Liban 2014 Jan-Mar;62(1):7-13

Aim Of The Study: To define the predictive factors of recurrence of the pediatric acquired cholesteatoma in order to improve the long-term results, to restore a good hearing function and to prevent the complications.

Patients And Methods: A retrospective study concerning all cases of pediatric acquired cholesteatoma, treated during the period 1997-2008 in our center, and followed up for at least one year. A description of the parameters concerning the patients, disease and treatment as well as a univariate analysis were undertaken in order to determine the recurrence predictors. Read More

View Article

Download full-text PDF

Source
April 2014
5 Reads

Acquired cholesteatoma presenting as a pars squamosa temporal bone mass.

Ear Nose Throat J 2014 Feb;93(2):E17-9

Department of Otolaryngology-Head and Neck Surgery, Northwestern Memorial Hospital, Chicago, IL, USA.

Acquired cholesteatomas typically arise in the middle ear and mastoid cavities; they rarely present elsewhere. We describe a case of acquired cholesteatoma that presented as a large mass of the pars squamosa of the temporal bone in a 16-year-old girl. The mass was surgically removed without complication. Read More

View Article

Download full-text PDF

Source
February 2014
4 Reads

The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.

Mediators Inflamm 2013 7;2013:651207. Epub 2013 Nov 7.

Department of Otolaryngology, Head and Neck Surgery, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, Hunan 410011, China.

Cholesteatoma is a benign keratinizing and hyper proliferative squamous epithelial lesion of the temporal bone. Epidermal growth factor (EGF) is one of the most important cytokines which has been shown to play a critical role in cholesteatoma. In this investigation, we studied the effects of EGF on the proliferation of keratinocytes and EGF-mediated signaling pathways underlying the pathogenesis of cholesteatoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/651207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839121PMC
June 2014
12 Reads

Evaluation of temporal bone cholesteatoma and the correlation between high resolution computed tomography and surgical finding.

Clin Med Insights Ear Nose Throat 2013 23;6:21-8. Epub 2013 Jul 23.

Department of Otorhinolaryngology, Faculty of Medicine, Minia University, Egypy.

Background: Acquired cholesteatomas are commonly seen in patients less than 30 years. There is a typical history of recurrent middle ear infections with tympanic membrane perforation. The diagnosis of cholesteatoma is usually made on otologic examination. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMENT.S10681
Publisher Site
http://dx.doi.org/10.4137/CMENT.S10681DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791954PMC
November 2013
49 Reads

The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.

Am J Otolaryngol 2013 Nov-Dec;34(6):652-7. Epub 2013 Aug 5.

Department of ENT, Cizre State Hospital, Sirnak, Turkey.

Objective: The aim of our study was to investigate the relationship between the destruction of temporal bone structures, ossicular chain destruction, dissemination of cholesteatoma and the expressions of bone morphogenetic proteins (BMPs), BMP-2, BMP-4 and BMP-6 in patients with acquired cholesteatoma.

Material And Methods: This study was performed in a total of 80 patients with cholesteatoma and without cholesteatoma who had undergone surgery due to chronic otitis media. The patients were grouped as the study and the control groups. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjoto.2013.06.007DOI Listing
October 2014
6 Reads

Management of acquired cholesteatoma in the pediatric population.

Curr Opin Otolaryngol Head Neck Surg 2013 Oct;21(5):440-5

Department of Otolaryngology/Head and Neck Surgery, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas 72205, USA.

Purpose Of Review: This review focuses on the most recent literature pertaining to pediatric acquired cholesteatoma and aims to integrate findings into a comprehensive management approach.

Recent Findings: Pediatric acquired cholesteatoma has been shown to differ from the adult variety secondary to anatomy and physiologic factors. Whereas the goals of therapeutic management are ultimately similar in adult and pediatric patients, special considerations must be taken into account when deciding on a treatment plan for a child. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOO.0b013e32836464bdDOI Listing
October 2013
5 Reads

Acquired cholesteatoma: summary of the cascade of molecular events.

Authors:
L Louw

J Laryngol Otol 2013 Jun 9;127(6):542-9. Epub 2013 May 9.

Department of Otorhinolaryngology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Background: Cholesteatoma is considered a benign, gradually expanding and destructive epithelial lesion of the temporal bone. The pathogenesis of different classifications of cholesteatoma is marked by similar underlying cellular and molecular processes. Stepwise explanations of the histopathogenesis have been described previously. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0022215113000601DOI Listing
June 2013
1 Read

Tympanomastoidectomy for cholesteatoma among Nigerians.

Eur Arch Otorhinolaryngol 2014 May 16;271(5):933-7. Epub 2013 Apr 16.

Department of Ear, Nose and Throat, National Hospital Abuja, Plot 132, Central Area Garki (Phase 2), Abuja, FCT 900001, Nigeria,

The incidence of cholesteatoma among Nigerians is not well documented, as is the outcome of surgical treatment. A descriptive analysis of prospectively collected data of cases of cholesteatoma managed with tympanomastoidectomy at National Hospital Abuja between September 2005 and April 2012 is presented. Cases were analyzed for age, sex, type of cholesteatoma, intra-operative findings, and post-operative outcome after 6 months of follow up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-013-2487-zDOI Listing
May 2014
3 Reads

Can long-term hearing preservation be expected in children following cholesteatoma surgery? Results from a 14-year-long study of atticotomy-limited mastoidectomy with cartilage reconstruction.

Audiol Neurootol 2012 28;17(6):386-94. Epub 2012 Aug 28.

Department of Otorhinolaryngology - Head and Neck Surgery, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.

Objective: Following cholesteatoma surgery, effective long-term hearing preservation in children is difficult and is not typically expected. Hence, long-term data on hearing outcomes are lacking. The aim of this study was to analyze long-term hearing outcomes in children following cholesteatoma surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000341985DOI Listing
March 2013
3 Reads
2 Citations
1.852 Impact Factor

Contemporary non-echo-planar diffusion-weighted imaging of middle ear cholesteatomas.

Radiographics 2012 Jul-Aug;32(4):1197-213

Departments of Radiology and ENT Surgery, Hospital Universitari í Politècnic La Fé de Valencia, Bulevar Sur s/n, 46026 Valencia, Spain.

Middle ear cholesteatoma is a common inflammatory disease that requires surgery due to potentially serious intracranial complications. Diagnosis of cholesteatoma is mainly clinical, with computed tomography (CT) used to evaluate disease extension before surgery. Certain patterns of bone erosion are specific, but CT attenuation does not allow differentiation from other inflammatory middle ear diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.324115109DOI Listing
December 2012
4 Reads

[Anatomical and functional results of open cavity tympanomastoidectomy].

Kulak Burun Bogaz Ihtis Derg 2012 Jul-Aug;22(4):207-13

Department of Otolaryngology, Tepecik Training and Research Hospital, İzmir, Turkey.

Objectives: In this study, we aimed to evaluate the anatomical and functional results of open cavity tympanomastoidectomy due to chronic otitis media with cholesteatoma.

Patients And Methods: Between January 2003 and October 2009, 166 patients who underwent open cavity tympanomastoidectomy due to chronic otitis media with cholesteatoma in our clinic were retrospectively analyzed. Seventy-two ears of 69 patients (40 males, 29 females; mean age 36. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5606/kbbihtisas.2012.040DOI Listing
March 2014
2 Reads

Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.

Braz J Otorhinolaryngol 2012 Jun;78(3):116-21

Medical Faculty of ABC.

Unlabelled: Acquired middle ear cholesteatoma is a benign keratinizing hyperproliferative squamous epithelial lesion that may result in the destruction of the bone structures surrounding the temporal bone. Recent studies show that variations in cellular production of matrix metalloproteinases (MMPs) and their specific inhibitors (TIMPs) contribute to the pathophysiology of cholesteatoma.

Objective: This study aims to analyze the use of RNA amplification tests to evaluate the expression of MMP and TIMP isoforms in cholesteatomas and their correlation with disease severity. Read More

View Article

Download full-text PDF

Source
June 2012
8 Reads

External ear canal cholesteatoma after ventilation tube insertion and mastoidectomy.

Vojnosanit Pregl 2012 Apr;69(4):363-6

Institute for Otorhinolaringology and Maxillofacial Surgery, Faculty of Medicine, University of Belgrade, Serbia.

Introduction: Etiopathogenetically, there are two types of chollesteatomas: congenital, and acquired. Numerous theories in the literature try to explain the nature of the disease, however, the question about cholesteatomas remain still unanswered. The aim of the study was to present a case of external ear canal cholesteatoma (EEC) developed following microsurgery (ventilation tube insertion and mastoidectomy), as well as to point ant possible mechanisms if its development. Read More

View Article

Download full-text PDF

Source
April 2012
14 Reads

Primary acquired cholesteatoma.

Ear Nose Throat J 2012 May;91(5):188

House Ear Clinic, Los Angeles, USA.

View Article

Download full-text PDF

Source
May 2012
28 Reads

The relationship between individual ossicular status and conductive hearing loss in cholesteatoma.

Otol Neurotol 2012 Apr;33(3):387-92

Department of Neurology and Neuroscience, Weill Cornell Medical College, New York, New York 10065, USA.

Objective: To investigate and analyze the relationship between individual ossicular erosion and air-bone gap (ABG) among patients with cholesteatoma.

Study Design: Retrospective case review.

Setting: Tertiary referral center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0b013e3182487fb0DOI Listing
April 2012
3 Reads

The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis.

Otol Neurotol 2012 Jan;33(1):42-7

Department of Otolaryngology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

Hypothesis: That acquired cholesteatoma of the human middle ear and mastoid process can be caused by migration of squamous epithelium from the tympanic membrane.

Objective: To provide histologic evidence in humans of the potential for medial epithelial migration toward the middle ear.

Background: The origin of cholesteatomas of the middle ear complex of humans is still not clearly understood. Read More

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00129492-201201000-000
Publisher Site
http://dx.doi.org/10.1097/MAO.0b013e31823c919cDOI Listing
January 2012
2 Reads

Detection of middle ear cholesteatoma by diffusion-weighted MR imaging: multishot echo-planar imaging compared with single-shot echo-planar imaging.

AJNR Am J Neuroradiol 2011 Nov-Dec;32(10):1915-8. Epub 2011 Jul 21.

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Background And Purpose: Previous reports have shown that DWI is useful in detecting cholesteatoma. SS-EPI is the most widely used DWI technique. However, SS-EPI may have susceptibility artifacts due to field inhomogeneity in the imaging of the temporal bone region. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3174/ajnr.A2651DOI Listing
March 2012
32 Reads

Acquired cholesteatoma: classification and outcomes.

Otol Neurotol 2011 Aug;32(6):992-5

Department of Otolaryngology, Royal Children's Hospital, Brisbane, Australia.

Objective: Reclassification of acquired cholesteatoma into the commonly observed presentations of this condition to provide a simple and clear grouping that indicates the pathology, management, and outcomes of the group cases.

Patients: Virgin acquired cholesteatoma cases from a single center managed from 1986 to 2008 (515 cases).

Interventions: Cases were managed by transcanal (20%) or intact canal wall techniques. Read More

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MAO.0b013e3182255874DOI Listing
August 2011
10 Reads